Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02147418 · ClinicalTrials.gov registry record
Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
A clinical trial, sponsored by New Mexico Cancer Research Alliance.
- Completed
- Registry status
- 15
- Enrollment target
NCT02147418 is a clinical trial that has completed, run by New Mexico Cancer Research Alliance. The registered enrollment target is 15 participants.
The verdict
NCT02147418 has completed, sponsored by New Mexico Cancer Research Alliance.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
Cancer of the oropharynx (middle, side and back walls of the throat; back of the tongue; soft palate, and tonsils), or oropharyngeal squamous cell carcinoma (OPSCC), has been on the rise in the United States. Human papillomavirus (HPV) has been recognized in many of these cancers, and testing for HPV has contributed to the higher reported rates of OPSCC. In this study, our goal is to develop a new test that can detect certain HPV proteins in the blood or saliva to help improve detection of OPSCC.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-02-25 |
| Est. Completion | 2024-07-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02147418
The ClinicalTrials.gov registry entry for NCT02147418 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New Mexico Cancer Research Alliance, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02147418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02147418 about?
NCT02147418 is a clinical study titled "Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma". Cancer of the oropharynx (middle, side and back walls of the throat; back of the tongue; soft palate, and tonsils), or oropharyngeal squamous cell carcinoma (OPSCC), has been on the rise in the United States. Human papillomavirus (HPV) has been recognized in many of these cancers, and testing for HP...
What is the current status of trial NCT02147418?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2015-02-25. Estimated completion is 2024-07-25.
Who is sponsoring clinical trial NCT02147418?
This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.